Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00069992
Status:
TERMINATED
Last Update Posted:
2012-10-10
First Post:
2003-10-03
Brief Title:
Total-Body Irradiation Fludarabine and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder MS AML or CML
Sponsor:
Baylor College of Medicine
Organization:
Baylor College of Medicine
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Chronic Myeloproliferative Disorders |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| childhood myelodysplastic syndromes | View |
| polycythemia vera | View |
| essential thrombocythemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| primary myelofibrosis | View |
| chronic myelogenous leukemia | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1517q22q12 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with t821q22q22 | View |